Biomea Fusion, Inc. (BMEA)
0.6119
-0.01
(-1.91%)
USD |
NASDAQ |
Nov 04, 16:00
0.6119
0.00 (0.00%)
After-Hours: 18:01
Biomea Fusion Market Cap : 44.35M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 45.22M |
| November 02, 2026 | 47.83M |
| October 30, 2026 | 46.35M |
| October 29, 2026 | 45.14M |
| October 28, 2026 | 46.95M |
| October 27, 2026 | 46.56M |
| October 26, 2026 | 46.07M |
| October 23, 2026 | 43.50M |
| October 22, 2026 | 42.40M |
| October 21, 2026 | 50.02M |
| October 20, 2026 | 53.32M |
| October 19, 2026 | 60.56M |
| October 16, 2026 | 62.98M |
| October 15, 2026 | 60.63M |
| October 14, 2026 | 60.45M |
| October 13, 2026 | 91.33M |
| October 12, 2026 | 98.58M |
| October 09, 2026 | 102.93M |
| October 08, 2026 | 99.30M |
| October 07, 2026 | 95.68M |
| October 06, 2026 | 90.60M |
| October 05, 2026 | 94.23M |
| October 02, 2026 | 92.05M |
| October 01, 2026 | 94.23M |
| September 30, 2026 | 96.40M |
| Date | Value |
|---|---|
| September 29, 2026 | 91.33M |
| September 28, 2026 | 93.50M |
| September 25, 2026 | 95.68M |
| September 24, 2026 | 108.00M |
| September 23, 2026 | 104.38M |
| September 22, 2026 | 123.22M |
| September 21, 2026 | 123.95M |
| September 18, 2026 | 132.65M |
| September 17, 2026 | 129.75M |
| September 16, 2026 | 126.12M |
| September 15, 2026 | 130.47M |
| September 14, 2026 | 129.02M |
| September 11, 2026 | 126.12M |
| September 10, 2026 | 123.22M |
| September 09, 2026 | 133.73M |
| September 08, 2026 | 139.89M |
| September 04, 2026 | 147.14M |
| September 03, 2026 | 138.44M |
| September 02, 2026 | 140.26M |
| September 01, 2026 | 130.47M |
| August 31, 2026 | 121.77M |
| August 28, 2026 | 125.40M |
| August 27, 2026 | 121.77M |
| August 26, 2026 | 123.95M |
| August 25, 2026 | 125.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 419.23M |
| Compass Therapeutics, Inc. | 138.31M |
| ACADIA Pharmaceuticals, Inc. | 3.701B |
| Alnylam Pharmaceuticals, Inc. | 21.54B |
| Anika Therapeutics, Inc. | 272.61M |
Market Cap Related Metrics
| Price to Book Value | 3.654 |
| Price | 0.6119 |
| Earnings Yield | -81.24% |